IVI Executive Director, Jennifer Bright, moderated a fascinating panel discussion on the quality-adjusted life-year (QALY) and whether there is room for a middle ground in the discussion about its merits and shortcomings. Lou Garrison, PhD, Assistant Director of the Pharmaceutical Outcomes Research and Policy Program at the University of Washington; Eleanor M. Perfetto, PhD, MS, Executive Vice President of the National Health Council; and Andrew Lloyd, DPhil, a health economics consultant from the United Kingdom participated in this discussion.
AJMC covered the panel and offers a recap here.
